PASQUINI, SERENA
 Distribuzione geografica
Continente #
NA - Nord America 1.759
EU - Europa 1.613
AS - Asia 281
AF - Africa 8
OC - Oceania 4
SA - Sud America 3
Totale 3.668
Nazione #
US - Stati Uniti d'America 1.755
GB - Regno Unito 486
IE - Irlanda 278
CN - Cina 203
UA - Ucraina 152
IT - Italia 145
SE - Svezia 143
DE - Germania 133
RU - Federazione Russa 103
FR - Francia 85
SG - Singapore 60
FI - Finlandia 53
BE - Belgio 10
TR - Turchia 9
CI - Costa d'Avorio 6
CA - Canada 4
NL - Olanda 4
VN - Vietnam 4
AU - Australia 3
CZ - Repubblica Ceca 3
ES - Italia 3
SK - Slovacchia (Repubblica Slovacca) 3
CH - Svizzera 2
CL - Cile 2
EE - Estonia 2
JP - Giappone 2
RO - Romania 2
AR - Argentina 1
AT - Austria 1
EG - Egitto 1
GR - Grecia 1
IR - Iran 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
Totale 3.668
Città #
Southend 465
Dublin 278
Fairfield 272
Woodbridge 155
Chandler 133
Ashburn 122
Wilmington 121
Jacksonville 120
Menlo Park 118
Houston 110
Cambridge 102
Seattle 83
Siena 83
Ann Arbor 72
Beijing 56
Nanjing 47
Singapore 47
Princeton 42
Fremont 25
Helsinki 24
Boardman 21
New York 17
Nanchang 14
Shenyang 13
San Diego 11
Brussels 9
Florence 9
London 9
Tianjin 9
Izmir 8
San Mateo 8
Shanghai 8
Hebei 7
Los Angeles 7
Moscow 7
Munich 7
Abidjan 6
Jiaxing 6
Changchun 5
Changsha 5
Düsseldorf 5
Kunming 5
Milan 5
Ningbo 5
Norwalk 5
Venezia 5
Bonndorf 4
Dearborn 4
Ho Chi Minh City 4
Bratislava 3
Brno 3
Grünheide 3
Guangzhou 3
Jinan 3
Mestre 3
Montreal 3
Málaga 3
Philadelphia 3
Rome 3
Taizhou 3
Zhengzhou 3
Edinburgh 2
Espoo 2
Frankfurt am Main 2
Hangzhou 2
Kazan' 2
Lappeenranta 2
Latina 2
Miami 2
Santa Clara 2
Southwark 2
Tallinn 2
Tappahannock 2
Zurich 2
Acton 1
Andover 1
Atlanta 1
Auckland 1
Bari 1
Belgrade 1
Buenos Aires 1
Cairo 1
Chisinau 1
Chiswick 1
Donetsk 1
Granarolo 1
Hanover 1
Hefei 1
Iasi 1
Isfahan 1
Islington 1
Lachine 1
Lagos 1
Lanzhou 1
Melbourne 1
Mountain View 1
Muscat 1
Nashville 1
Nuremberg 1
Odesa 1
Totale 2.791
Nome #
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach 208
1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamide: An effective scaffold for the design of either CB1 and CB2 receptor ligands 204
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury 187
Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA B receptor 180
New fluoroquinolones active against fluoroquinolones-resistant Mycobacterium tuberculosis strains 173
Synthesis, Cannabinoid Receptor Affinity, and Molecular Modeling Studies of Substituted 1-Aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides 156
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 6. Synthesis and Pharmacological Evaluation of 7-Substituted 4-Quinolone-3-carboxamide Derivatives as High Affinity Ligands for Cannabinoid Receptors 152
Synthesis and biological evaluation of New N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands 151
Rapid combinatorial access to a library of 1,5-disubstituted-3-indole-N-alkylacetamides as CB2 receptor ligands 151
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 1. Synthesis and Structure-Activity Relationship of a Class of Human Immunodeficiency Virus type 1 Integrase Inhibitors 149
Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice 144
Design, Synthesis, and Pharmacological Characterization of Indole-3-ylacetamides, Indole-3-yloxoacetamides, and Indole-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists 144
Regioselective functionalization of quinolin-4(1H)-ones via sequential palladium-catalyzed reactions 143
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo 143
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice 140
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 3. Synthesis, Structure-Affinity Relationships, and Pharmacological Characterization of 6-Substituted 4-Quinolone-3-carboxamides as Highly Selective Cannabinoid-2 Receptor Ligands 135
Reduction by the positive allosteric modulator of the GABAB receptor, GS39783, of alcohol self-administration in Sardinian alcohol-preferring rats exposed to the “sipper” procedure 134
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists 132
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile. 131
Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 2. Synthesis and Structure-Activity Relationship of Potent and Selective Cannabinoid-2 Receptor Agonists Endowed with Analgesic Activity in Vivo 129
Three-Dimensional Quantitative Structure-Selectivity Relationships (3D-QSSR) Analysis Guided Rational Design of a Highly Selective Ligand for the Cannabinoid Receptor 2 126
The 4-Quinolone-3-carboxylic Acid Motif as a Multivalent Scaffold in Medicinal Chemistry 124
The bioisosteric concept applied to cannabinoid ligands 121
Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase 117
Comparison of the effect of the positive allosteric modulator of the GABAb receptor, GS39783, on alcohol self-administration in three different lines of alcohol-preferring rats 100
Totale 3.674
Categoria #
all - tutte 11.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020447 0 0 0 0 52 63 55 97 62 54 24 40
2020/2021524 26 54 6 65 35 75 29 70 68 29 42 25
2021/2022307 34 48 14 28 7 9 18 15 8 33 24 69
2022/2023488 29 36 75 58 50 105 10 47 51 7 11 9
2023/2024427 14 7 36 54 9 98 163 14 0 1 3 28
2024/2025204 14 34 97 38 21 0 0 0 0 0 0 0
Totale 3.674